Several important factors such as the result of CMV detection and CD4+ T lymphocyte counts have been identified for early clinical diagnosis of CMV retinitis when CMV retinitis is not typical and prophylactic treatment of anti-CMV drug is recommended when the CD4+ T lymphocyte count is less than 50 cells/μl in AIDS patients. This evidence concerns the gene CD4 and cytomegalovirus retinitis.